AbbVie: Margin Expansion Potential Can Support Elevated P/E

Group 1 - The last analysis on AbbVie Inc. (NYSE: ABBV) stock was published over a month ago, comparing it with Johnson & Johnson [1] - The article emphasized actionable and clear investment ideas derived from independent research [1] Group 2 - The service has assisted members in outperforming the S&P 500 and avoiding significant drawdowns amid extreme market volatility in both equity and bond markets [2] - A trial membership is available to evaluate the effectiveness of the proven investment method [2]